Dr. Reddy’s Announces the Launch of Ibandronate Sodium Tablets. Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Ibandronate Sodium tablets (150 mg), a bioequivalent generic version of BONIVA ® tablets in the US market on June 29, 2012 following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy’s ANDA for Ibandronate sodium tablets.
Visit At :
eon.businesswire.com/news/eon/20120701005066/en
No comments:
Post a Comment